Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis
American Journal of Cardiovascular Drugs · 2025-01 · 25 (1) · 57-69
DOI: 10.1007/s40256-024-00684-y ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Cardiovascular Drugs, online erschienen am 11.10.2024. Verfasst von Kyriakos Dimitriadis und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias …. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Contrast Media, Acute Kidney Injury, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION: Contrast-induced acute kidney injury (CI-AKI) is a common complication of iodinated contrast administration during coronary procedures, especially in patients with diabetes mellitus (DM). Besides periprocedural hydration and statins, there are no other pharmacological strategies with consistent results to prevent CI-AKI up to date. This study aims to evaluate the efficacy of chronic use of sodium-glucose co-transporter 2 (SGLT2) inhibitors on the prevention of CI-AKI in patients with type 2 DM following coronary procedures. METHODS: A systematic literature search of MEDLINE, Google Scholar, Embase, and Cochrane Library was performed. Relevant observational studies and randomized controlled studies (RCTs) were identified. Results were pooled using a random-effect model meta-analysis. Subgroup analyses were performed to evaluate the potential benefit of SGLT2 inhibitors on the prevention of CI-AKI in patients undergoing urgent or elective coronary angiography/percutaneous coronary interventions (CAG/PCI). RESULTS: Seven observational studies and one randomized controlled trial with 2740 patients were included. Chronic treatment (minimum duration 2 weeks to 6 months) with an SGLT2 inhibitor was associated with a significantly reduced risk of CI-AKI in diabetic patients undergoing coronary procedures compared with the control group [risk ratio (RR) 0.48; 95% confidence interval (CI) 0.39-0.59; p < 0.001). Results of subsequent subgroup analysis showed a significant reduction in the incidence of CI-AKI in diabetic patients undergoing both elective CAG/PCI (RR 0.49; 95% CI 0.35-0.68; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, 115 27, Athens, Greece. dimitriadiskyr@yahoo.gr.
- First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Vasilissis Sofias 114, 115 27, Athens, Greece.
- Service of Nephrology, Hippokration General Hospital, University Hospital of Athens, Athens, Greece.
Zitieren
APA
Dimitriadis, K., Vakka, A., Pyrpyris, N., Apostolos, A., Beneki, E., Stathopoulou, E., Giannou, P., Tsioufis, P., Iliakis, P., Aznaouridis, K., Petras, D., & Tsioufis, K. (2025). Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs, 25(1), 57-69. https://doi.org/10.1007/s40256-024-00684-y
Vancouver
Dimitriadis K, Vakka A, Pyrpyris N, Apostolos A, Beneki E, Stathopoulou E, et al. Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs. 2025;25(1):57-69. doi:10.1007/s40256-024-00684-y
BibTeX
@article{Dimitriadis2025,
author = {Dimitriadis, Kyriakos and Vakka, Angeliki and Pyrpyris, Nikolaos and Apostolos, Anastasios and Beneki, Eirini and Stathopoulou, Elpiniki and Giannou, Panagiota and Tsioufis, Panagiotis and Iliakis, Panagiotis and Aznaouridis, Konstantinos and Petras, Dimitrios and Tsioufis, Konstantinos},
title = {Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis},
journal = {American Journal of Cardiovascular Drugs},
year = {2025},
volume = {25},
number = {1},
pages = {57--69},
doi = {10.1007/s40256-024-00684-y}
}
EUVIMED